This company has been marked as potentially delisted and may not be actively trading. Leisure Acquisition (LACQ) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock LACQ vs. PYRGF, ELYM, ATNM, OSTX, NBRV, AADI, EGRX, NNVC, HILS, and IBIOShould you be buying Leisure Acquisition stock or one of its competitors? The main competitors of Leisure Acquisition include PyroGenesis Canada (PYRGF), Eliem Therapeutics (ELYM), Actinium Pharmaceuticals (ATNM), OS Therapies (OSTX), Nabriva Therapeutics (NBRV), Aadi Bioscience (AADI), Eagle Pharmaceuticals (EGRX), NanoViricides (NNVC), Hillstream BioPharma (HILS), and iBio (IBIO). Leisure Acquisition vs. Its Competitors PyroGenesis Canada Eliem Therapeutics Actinium Pharmaceuticals OS Therapies Nabriva Therapeutics Aadi Bioscience Eagle Pharmaceuticals NanoViricides Hillstream BioPharma iBio Leisure Acquisition (NASDAQ:LACQ) and PyroGenesis Canada (NASDAQ:PYRGF) are both small-cap pharmaceutical preparations industry companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, institutional ownership, media sentiment, valuation, profitability and risk. Do insiders and institutionals believe in LACQ or PYRGF? 56.7% of Leisure Acquisition shares are held by institutional investors. Comparatively, 0.0% of PyroGenesis Canada shares are held by institutional investors. 39.6% of Leisure Acquisition shares are held by company insiders. Comparatively, 47.7% of PyroGenesis Canada shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Which has more risk and volatility, LACQ or PYRGF? Leisure Acquisition has a beta of -0.3, meaning that its stock price is 130% less volatile than the S&P 500. Comparatively, PyroGenesis Canada has a beta of 0.83, meaning that its stock price is 17% less volatile than the S&P 500. Is LACQ or PYRGF more profitable? Leisure Acquisition has a net margin of 0.00% compared to PyroGenesis Canada's net margin of -115.14%. Leisure Acquisition's return on equity of 30.17% beat PyroGenesis Canada's return on equity.Company Net Margins Return on Equity Return on Assets Leisure AcquisitionN/A 30.17% 6.14% PyroGenesis Canada -115.14%N/A -60.81% Which has preferable valuation and earnings, LACQ or PYRGF? Leisure Acquisition has higher earnings, but lower revenue than PyroGenesis Canada. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLeisure AcquisitionN/AN/A$4.31MN/AN/APyroGenesis Canada$9.14M5.62-$21.12M-$0.03-9.13 Does the media favor LACQ or PYRGF? In the previous week, Leisure Acquisition had 1 more articles in the media than PyroGenesis Canada. MarketBeat recorded 1 mentions for Leisure Acquisition and 0 mentions for PyroGenesis Canada. PyroGenesis Canada's average media sentiment score of 0.00 beat Leisure Acquisition's score of -1.38 indicating that PyroGenesis Canada is being referred to more favorably in the news media. Company Overall Sentiment Leisure Acquisition Negative PyroGenesis Canada Neutral SummaryLeisure Acquisition beats PyroGenesis Canada on 6 of the 10 factors compared between the two stocks. Get Leisure Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for LACQ and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LACQ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LACQ vs. The Competition Export to ExcelMetricLeisure AcquisitionPharmaceutical Preparations Industry SectorNASDAQ ExchangeMarket Cap$13.01M$816.12M$2.07B$9.83BDividend YieldN/A4.84%13.69%4.11%P/E RatioN/A1.2012.2926.03Price / SalesN/A36.573,073,992.26104.94Price / Cash20.0319.5657.5458.93Price / Book-11.006.583.106.06Net Income$4.31M-$4.11M-$456.46M$265.11M Leisure Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LACQLeisure AcquisitionN/A$2.09+0.5%N/A+434.7%$13.01MN/A0.00N/ANews CoverageNegative NewsGap DownHigh Trading VolumePYRGFPyroGenesis CanadaN/A$0.29+1.0%N/A-54.0%$54.26M$9.14M-4.8390Gap UpELYMEliem TherapeuticsN/A$1.70+17.2%N/A-72.5%$50.58MN/A-3.219High Trading VolumeATNMActinium Pharmaceuticals2.905 of 5 stars$1.60-1.2%$3.67+129.2%-24.1%$49.91MN/A-1.1530Analyst RevisionOSTXOS Therapies2.2695 of 5 stars$1.75+1.7%$18.00+928.6%-51.2%$49.17MN/A-2.03N/ANBRVNabriva TherapeuticsN/AN/AN/AN/A$45.46M$35.59M0.0070AADIAadi Bioscience0.4633 of 5 stars$1.77+0.6%$1.67-5.8%+22.5%$43.71M$25.07M-0.7840EGRXEagle PharmaceuticalsN/A$3.19flatN/A-21.0%$41.43M$257.55M0.00100NNVCNanoViricides0.2718 of 5 stars$1.59+0.6%N/A-13.0%$25.55MN/A-2.2120HILSHillstream BioPharmaN/A$1.22-8.3%N/A-59.0%$21.48MN/A-1.691IBIOiBio1.1218 of 5 stars$0.60-4.5%$5.00+740.3%-63.7%$9.83M$375K0.00100 Related Companies and Tools Related Companies PYRGF Alternatives ELYM Alternatives ATNM Alternatives OSTX Alternatives NBRV Alternatives AADI Alternatives EGRX Alternatives NNVC Alternatives HILS Alternatives IBIO Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LACQ) was last updated on 8/13/2025 by MarketBeat.com Staff From Our PartnersBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Leisure Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Leisure Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access